Controlled trial
[대역어] 통제 된 시험
[용어속성] Term
[용어속성] Term
The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis
스타틴의 사용은 COVID-19 사망률 감소와 관련이 있습니다 : 체계적인 검토 및 메타 분석
Meta-Analysis
[키워드] 95% CI
95% confidence interval
Admission
all-cause mortality
Analysis
association
benefit
Cardiovascular disorders
Care
Controlled trial
coronavirus disease
Coronavirus disease 2019
COVID-19
death
decreased mortality
described
dichotomous variables
FIVE
ICU
ICU care
identify
IMV
individuals with COVID-19
intensive care
intensive care unit
invasive mechanical
Invasive mechanical ventilation
material
mechanical ventilator
meta-analyses
Meta-analysis
Mortality
not need
observational studies
Odds ratio
on admission
outcome
outcomes
participant
Prevent
random-effect
Randomized controlled trial
Randomized controlled trials
RCTs
reduced
Result
SARS-CoV-2
severe COVID-19
shown
significantly
statin
statins
subgroup analysis
Support
systematic review
treat
ventilator
were measured
[DOI] 10.1080/07853890.2021.1933165 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1080/07853890.2021.1933165 PMC 바로가기 [Article Type] Meta-Analysis
Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis
Review
[키워드] 95%CI
adverse events
all-cause mortality
analyses
caused
clearance
clinical recovery
Controlled trial
controls
COVID-19
discharge
dose
Efficacy and safety
Hospitalization
hospitalized COVID-19
hospitalized COVID-19 patient
hospitalized COVID-19 patients
Hydroxychloroquine
ICU admission
increased mortality
inverse
mechanical ventilation
Meta-analysis
Mortality
non-invasive ventilation
not affect
outcome
oxygen support
performed
Pneumonia
radiological progression
random effect
ranged
RCT
RCTs
review
SAE
Safety
searched
secondary
Secondary outcomes
Serious Adverse Event
severe adverse events
significantly higher
subgroup analysis
Treatment
worsening
[DOI] 10.3390/jcm10112503 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm10112503 PMC 바로가기 [Article Type] Review
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
Observational Study
[키워드] 95% CI
accounted
Anticoagulant
anticoagulant therapy
anticoagulation
bleeding
clinical
collected
consecutive patient
Controlled trial
COVID-19
Critically ill patient
defined
dose
eight
favor
French
hazard ratio
hemorrhage
hemorrhagic events
high risk
High-dose
ICU
ICU admission
Ill
Impact
incidence
increased risk
laboratory data
Patient
Probability
Prophylactic
Prophylaxis
Pulmonary embolism
recorded
reduced risk
reduction in
risk
SARS-COV-2 infection
standardized protocol
therapeutic
thrombosis
thrombotic
thrombotic complication
Treatment
with COVID-19
[DOI] 10.1016/j.chest.2021.01.017 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.chest.2021.01.017 PMC 바로가기 [Article Type] Observational Study
Effect of a mobile-based intervention on mental health in frontline healthcare workers against COVID-19: Protocol for a randomized controlled trial
COVID-19에 대한 최전선 의료 종사자의 정신 건강에 대한 모바일 기반 개입의 영향: 무작위 대조 시험 프로토콜
Article
[키워드] Anxiety
app
approach
approved
baseline
blinded
Burnout
Care
clinical
Cognitive behavioural therapy
collected
control group
Controlled trial
COVID-19
DASS
DASS-21
data analyst
Depression
Doctors
DTS
Effect
Effectiveness
eHealth
emotional
Endpoint
evaluate
Evidence
Features
FIVE
frontline healthcare worker
Group allocation
GSE
Health
Health care
Health Service
Health services
healthcare
healthcare worker
Healthcare workers
help
Identifier
implementation
include
individually randomized
infancy
Insomnia
Intervention
intervention group
ISI
lack
MBI-HSS
measure
Mental
mental health
mental health care
mindfulness
Mindfulness-based
Mobile health
mobile health intervention
mobile health interventions
mobile-based intervention
Nurses
organization
organizations
outcome assessor
outcome assessors
parallel group
participant
Participants
patients with COVID-19
Post-traumatic stress disorder
protocol
psychoeducational
psychologist
psychologists
PsyCovidApp intervention
Randomized
Randomized controlled trial
receive
Research
scientific evidence
Self-efficacy
smartphone-based psychoeducation.
Social support
Spain
Statistical power
Stress
Support
team
Trial
trial participants
[DOI] 10.1111/jan.14813 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/jan.14813 PMC 바로가기 [Article Type] Article
Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trial
Research article
[키워드] 1:1
95% CI
activity
adverse event
Affect
age
allocation to intervention
analysed
Anxiety
anxiety symptom
anxiety symptoms
assigned
baseline
Canada
Complete
Controlled trial
coping strategies
COVID-19
Depression
Effect
Effectiveness
eligible
Emergency
evaluate the effect
finding
funding
group
IMPROVE
initiative
Intention-to-treat analyses
intention-to-treat population
International
Intervention
Isolation
mean difference
measure
mental health
Mild
network
New
outcome
participant
Participants
Patient
positive
post-intervention
Pragmatic
Primary outcome
Program
programming
provided
public health
randomised
Randomly
receiving
recruited
reduce
reduced
Registered
reported
Scleroderma
secondary outcome
significantly
significantly lower
SMD
Society
South
Support
Symptom
Systemic sclerosis
tested
Trial
Two-arm
two-arm parallel
white
women
[DOI] 10.1016/S2665-9913(21)00060-6 [Article Type] Research article
[DOI] 10.1016/S2665-9913(21)00060-6 [Article Type] Research article
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial
치료 중인 암 환자의 COVID-19 예방에 대한 하이드록시클로로퀸의 효과: 무작위 대조 시험을 위한 연구 프로토콜
Update
[키워드] 1:1
age
assigned
blinded
Blinding
blocks
breast and colon cancer
calculated
Cancer
cancer patient
Cancer patients
Caregivers
Colon cancer
color
company
comparator Patients
control group
Controlled trial
coronavirus disease
COVID-19
COVID-19 symptom
COVID-19 symptoms
curative intent
Effect
examined
FIVE
follow-up period
high resolution
Hydroxychloroquine
incidence of COVID-19
Intervention
investigated
Iran
leukemia
lung
Lungs
lymphoid
Mashhad
Medical Sciences
Nasopharyngeal swab
non-Hodgkin’s lymphoma
Novel coronavirus
novel coronavirus disease
objective
occur
outcome
parallel-group
participant
Patient
patients
performed
pharmaceutical
Pharmaceutical Company
Placebo
primary end point
produced
Prophylactic
random
randomization sequence
Randomized controlled trial
Randomly
receiving
regimens
RT-PCR
Sample
Sample size
SARS-CoV-2 virus
shape
Study protocol
supplementary material
Symptom
Tablet
the patient
tomography
total sample size
treated
Treatment
triple-blind
two group
two groups
Two-arm
university
website
[DOI] 10.1186/s13063-021-05292-8 PMC 바로가기 [Article Type] Update
[DOI] 10.1186/s13063-021-05292-8 PMC 바로가기 [Article Type] Update
A Mobile Phone–Based Intervention to Reduce Mental Health Problems in Health Care Workers During the COVID-19 Pandemic (PsyCovidApp): Randomized Controlled Trial
COVID-19 전염병 동안 의료 종사자의 정신 건강 문제를 줄이기 위한 휴대전화 기반 개입(PsyCovidApp): 무작위 통제 시험
Randomized Controlled Trial
[키워드] 1:1
95% CI
analyses
analyzed
Anxiety
app
asked
assigned
baseline
blinded
Burnout
Care
collected
Complete
Composite
conducted
Controlled
Controlled trial
COVID-19
COVID-19 pandemic
DASS
DASS-21
Davidson Trauma Scale
Depression
Depression Anxiety Stress Scale-21
difference
Effectiveness
Efficacy
emotional
evaluate
Evidence
face-to-face health care
Features
General Self-Efficacy Scale
group
Health
Health care
Health care worker
health care workers
health emergency
health problems
healthy
Human
implementation
improvement
Improvements
Insomnia
Insomnia Severity Index
intention-to-treat
Intervention
intervention group
inventory
lack
linear modeling
Maslach Burnout Inventory Human Services Survey
mental health
mental health care
mental health problem
mental health problems
mHealth
mHealth intervention
mindfulness-based mHealth intervention
Mobile
no significant differences
objective
Other outcomes
outcome
outcomes
parallel-group
participant
patients with COVID-19
Posttraumatic Stress
Primary outcome
problem
protocol
psychoeducational
psychologically difficult situations
psychologists
psychotherapy
Psychotropic medication
psychotropic medications
PsyCovidApp
PsyCovidApp intervention
Randomized controlled trial
Randomly
receive
receiving
recommendation
recruited
reduce
reduced
Registration
Result
secondary
Secondary outcomes
Self-efficacy
service
significant difference
Social support
Spain
standardized mean difference
statistician
Stress
Stress Scale
Support
survey
System Usability Scale
trauma
treat
treatment allocation
Trial
Usability
were blinded
worker
[DOI] 10.2196/27039 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.2196/27039 PMC 바로가기 [Article Type] Randomized Controlled Trial
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial
초기 SARS-CoV-2 Q-PCR 양성 고위험 개인(RES-Q-HR)의 회복기 혈장/카모스타트 메실레이트: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] accommodation
acts
Administered
administration
Adult patients
Adverse
adverse events
alcohol
Alcohol Abuse
ALT
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
anticancer
Antiviral
antiviral therapy
appearance
approved
AST
blinded
Blinding
BMI
body weight
Bone marrow
Breastfeeding
CAD
camostat
Camostat mesylate
Capsule
Care
Caregivers
Cell
Child
chronic
Chronic kidney disease
chronic obstructive pulmonary disease
chronic obstructive pulmonary disease (COPD)
cirrhosis
CKD
clinical
clinical condition
Compliance
Concomitant
concurrent
conducted
control group
Controlled trial
convalescent plasma
COPD
Coronary artery
Coronary artery disease
cough
COVID-19
COVID-19 pneumonia
criteria
cumulative
defined
diabetes
Diabetes Mellitus
diagnosed
diagnosis of SARS-CoV-2
diarrhea
disease
Disease progression
disease stage
disorder
dissemination
double-blind
Duration
early disease
Early phase of SARS-CoV-2 infection
Efficacy
element
enrolled
Enrollment
enrolment
EudraCT
evaluate
evening
event
evidence of
Exanthema
excluded
exclusion criteria
fatigue
Fever
fibrosis
Germany
GFR
half-live
headache
high risk
higher risk
Hospitalization
Hospitalized
host cell
hypersensitivity
IgA deficiency
immunization
Inclusion
inclusion criteria
increased risk
independent
individual
Infection
infection with SARS-CoV-2
Influenza
influenza A
Informed consent
inhibitor
institution
intervention arm
intervention arms
Kidney disease
less
Life expectancy
likelihood
Liver cirrhosis
Local
local Ethics Committee
Mask
mesylate
moderate
mother
multicenter
nasal
nasal cannula
Neutralizing
number
objective
Obstructive
obstructive pulmonary disease
Older
Ordinal Scale
organ
outcome
outcomes
oxygen
oxygen demand
Pancreatitis
parallel group
participant
Participants
passive immunization
Patient
patients hospitalized
PCR
Placebo
plasma
Plasma transfusion
Pneumonia
positive
pregnant women
Presence
Prevent
prevent disease progression
primary endpoint
progression
protocol
pulmonary disease
pulmonary fibrosis
Q-PCR
randomization
Randomized
Randomized controlled trial
receive
recruitment
reduce
Regulatory
reported
risk factor
safety monitoring committee
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 PCR
screening visit
Serine
serine protease TMPRSS2
Serious Adverse Event
Serious Adverse Events
severe COVID-19
Shortness of breath
SOC
sore throat
Stage
Standard
Standard of care
stratified
Stress
Study protocol
supplementary material
Symptom
symptom duration
Symptoms
tertiary care center
tested
the cell
titers
TMPRSS2
transfusion reaction
Treatment
treatment arm
Trial
Trial registration
Tumor
typical symptom
typical symptoms
ULN
virus
website
WHO
with COVID-19
women
working hypothesis
written Informed Consent
[DOI] 10.1186/s13063-021-05181-0 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05181-0 PMC 바로가기 [Article Type] Letter
Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy?
코로나19 단계별 치료, 중간엽줄기세포 치료 여지는?
Review
[키워드] acute respiratory distress syndrome
approach
Cell
Cell therapy
China
Controlled trial
controlled trials
coronavirus
COVID-19
Cytokine storm
death
develop
disease severity
Diseases
Efficacy
effort
epithelial cells
focus
immune
immune response
Infection
Inflammation
Inflammatory
inhibit
mesenchymal stem cell
Mesenchymal stem cells
Numerous
Organ failure
Pandemics
Patient
Premature
Prevent
protocol
Result
SARS-CoV-2 entry
severe COVID-19
severity
shown
stem cell
Stem cell therapy
the cell
the disease
therapeutic
therapy
Treatment
Trial
USA
vascular cells
Viral
[DOI] 10.2217/rme-2020-0189 PMC 바로가기 [Article Type] Review
[DOI] 10.2217/rme-2020-0189 PMC 바로가기 [Article Type] Review